About
Novavax develops protein-based nanoparticle vaccines enhanced with their proprietary Matrix-M adjuvant to create strong and durable immune responses against infectious diseases.
Explore Novavax's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.